Arrivent Biopharma Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Arrivent Biopharma Inc had 62.10M in cash and cash equivalents.

As of the latest reported quarter, Arrivent Biopharma Inc's total assets were 333.17M, consisting of 332.90M in current assets and 272.00K in non-current assets.

Arrivent Biopharma Inc reported 307.22M in total shareholders' equity as of the latest reported quarter.